Palleos Healthcare has a distinguished history of advancing medical innovations, leveraging its extensive experience and network to accelerate the development of new therapies. By integrating academic ...

The positive results from the double-blind period of the RISE UP Phase 2 study, which were presented at the 65 th American Society of Hematology (ASH) Annual Meeting & Exposition in December 2023, ...

Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy that combines the precision of monoclonal antibodies with the potency of ...

Despite global clinical trials increasing by 38% over the past decade, the European Economic Area’s (EEA) global share of trials has halved over the same period. A new report by IQVIA for EFPIA and ...

An invited Guest Editorial entitled “Give Cas a Chance,” by Fyodor Urnov, PhD, Director of Technology & Translation at the ...

Disruption is a pressing problem in the pharmaceutical world; patient health depends on clinical trial organisers avoiding it ...